{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Cardiac Index-Guided Therapy in Major Abdominal Surgery"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomised to either cardiac index-guided therapy or routine care."
      },
      "Participants": {
        "score": 2,
        "evidence": "Conducted in three German and two Spanish centres, this multicentre randomised controlled trial enrolled 380 high-risk patients."
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention involved maintaining a cardiac index at which pulse pressure variation was <12% using intravenous fluids and dobutamine."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to determine if maintaining an optimised postinduction cardiac index during and for the first 8 hours after surgery reduces postoperative complications in high-risk patients undergoing elective major open abdominal surgery."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the incidence of a composite of moderate or severe complications within 28 days post-surgery."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Patients were blinded to group allocation, but clinicians and outcome assessors were not."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "this multicentre randomised controlled trial enrolled 380 high-risk patients."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Of the 380 enrolled, 318 were analysed (152 in the intervention group and 166 in the control group) using a modified intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The composite primary outcome occurred in 55% of the intervention group and 46% of the control group (odds ratio: 1.87, 95% CI: 1.03\u20133.39, P = 0.038)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT03021525."
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: Pulsion Medical Systems, Germany, and institutional and departmental sources."
      }
    },
    "total_score": 21,
    "max_score": 25
  },
  "model": "gpt-4o"
}